WHO ICTRP trial
Diagnostic feasibility of PET examination with use of [18F]-Fluorocholin inj. in…
EUCTR2014-005345-50-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-005345-50-CZ |
|---|---|
| Public title | Diagnostic feasibility of PET examination with use of [18F]-Fluorocholin inj. in patients with prostate carncer |
| Scientific title | Diagnostic feasibility and morfological and functional correlation of PET examination in use of [18F]-Fluorocholin inj. in patients with prostate cancer - Fluoromethylcholinium-(18F)-chlorid inj. |
| Primary sponsor | Masarykuv onkologický ústav |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Czech Republic |
| Conditions | Prostate cancer MedDRA version: 17.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer… |
| Interventions | Product Name: [18F]-Fluorocholin inj. Pharmaceutical Form: Solution for injection INN or Proposed INN: [18F]- Fluorocholin Other descriptive name: FLUOROMETHYL-(18F)-DIMETHYL-2-HYDROXYETHYL-AMMONIUM Concentration unit: MBq megabecquerel(s)… |
| Registration date | Mar 3, 2015 |
| Secondary IDs | RD-FCH-2014 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: